Quimioterapia neoadjuvante torna ressecável carcinoma de cabeça de pâncreas

Revista do Colégio Brasileiro de Cirurgiões

Marco Antônio Cezário De Melo²  Christiane Violet¹ 

[1] ,DIGESTRecife PE

关键词: Pancreatic neoplasms;    Pancreaticoduodenectomy;    Drug therapy;    Neoadjuvant therapy;    Gemcitabine;   

DOI  :  10.1590/S0100-69912007000400014

来源: SciELO

【 摘 要 】

We present a case of non-resectable head pancreatic cancer by mesenteric venous invasion in which treatment with Gemcitabine (Gemzar) 1.000 mg/m 2 weekly for 3 weeks, followed by a 1-week rest, normalized CA 19.9 and promoted tumor resecability in a second operation (ultrasound, helicoidal tomography and magnetic ressonance exams). The value of the adjuvant treatment (radiochemotherapy) and the association with immunotherapy (Interferon) is discussed.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License